Ceeli Thairianathan: Bridging Biotechnology and Clinical Application
Ceeli Thairianathan, Northeastern Graduate Student, shared a post on LinkedIn:
“Bridging Biotechnology and Clinical Application: Key Insights from Biocytogen
As a biotechnology graduate student, I recently attended a webinar by Biocytogen on the critical role of humanized models in navigating the complexities of cardio-metabolic drug discovery.
Here is a concise technical summary of the platform’s capabilities:
1. Next-Gen Anticoagulation:
Biocytogen is utilizing B-hFXI and B-hFXII plus mice to target the intrinsic coagulation pathway.
This strategy aims to uncouple dangerous thrombosis from essential physiological hemostasis.
2. Precision Cardiomyopathy Models:
The B-Mybpc3 KO model demonstrates high phenotypic fidelity to human disease, exhibiting cardiac enlargement and ventricular wall thickening.
Masson-staining in 17-week-old models provides clear evidence of endocardial collagen fiber proliferation.
3. Systemic Metabolic Solutions:
Advanced multi-target models, such as the B-hLPA/hAPOB/hPCSK9 plus mice, are engineered to evaluate therapies for atherosclerosis and hyperlipidemia.
The broader portfolio addresses NAFLD/MASH, Hyperuricemia, and Diabetic Nephropathy.
4. Integrated Assay Platform:
Beyond the models, Biocytogen provides a robust analytical framework including MSD, FACS, and Luminex to support comprehensive PK/PD/Tox/MoA studies.
These integrated preclinical solutions are essential for accelerating the transition from laboratory research to successful IND filing.
I am grateful for the expert insights shared during this session, which underscored the importance of humanized precision in modern drug discovery.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention